Kreivo Health, Your Partner for Entering the MEA Healthcare Market
16 MARCH 2024
As a boutique healthcare consulting company, we are thrilled to announce our strategic expansion into the Middle East and Africa (MEA) market, motivated by promising regional trends and increasing client interest.
Building upon our successful cultivation across Europe and Asia, we're thrilled to extend our support into the dynamic MEA region. With a proven track record of facilitating growth and expansion, we're driven to empower companies in their journey to broaden their reach, serve more patients, and flourish in potential new markets. As we embark on this new chapter, our goal remains unchanged: to be the gateway for our partners' full potential across Europe, Asia and MEA . The MEA region offers a fertile ground for opportunity, driven by increasing incomes, substantial R&D investments exceeding $10 billion, and a burgeoning ecosystem of life sciences innovation. Leveraging our expertise in navigating regulatory complexities, go to market strategies and cultivating local alliances, we're committed to equipping our partners with the tools they need to succeed.
Kreivo Health obtains GDPMDS certification
9 JUNE 2022
We at Kreivo Health are pleased to announce that we have obtained GDPMDS certification. The Good Distribution Practice for Medical Devices (GDPMDS) is mandatory for any organizations involved with importing, wholesale and distribution of medical devices prior to their license application. GDPMDS certification demonstrates that medical device products are consistently stored, transported and handled under suitable and appropriate conditions.
Obtaining GDPMDS certification demonstrates Kreivo Health's commitment to ensuring our internal processes are of a high standard and bringing in high quality medical device products that meet our customer's needs.
Micron supports >25% SaMD approvals in Japan
17 MAY 2022
Micron, our valuable partner, recently released research on Software as a Medical Device (SaMD) product registration and approvals in Japan. Research showed that as of December 31, 2021, there were 30 approved software programs for disease diagnosis in the controlled medical device category in Japan. Out of these, 8 (more than 25%) were supported by Micron. As a CRO, Micron supports the development of pharmaceuticals and medical devices, as well as the registration, manufacturing and sales of SaMD products.
Reach out to us now for support with SaMD applications and approvals in Japan.
Kreivo Health announces expansion of partnership with Micron
14 APR 2022
We at Kreivo Health are excited to announce that we have expanded our partnership with Micron to offer support with medical device registration in Japan. We will leverage Micron’s experience as a medical device manufacturer in Japan and leading imaging CRO in Asia as well as our own in-house expertise in market access strategies to companies in need of support.
Kreivo Health announces partnership with Micron
01 SEP 2021
We at Kreivo Health are very honoured to announce that we have signed an agreement with Micron. Our experts will support Micron in Go-To-Market activities in Taiwan.
Epilog wins the inaugural Healthcare InnoMatch by Temasek Foundation and Singapore’s Centre for Healthcare Innovation
25 AUG 2021
Congratulations to our client Epilog for winning a prestigious healthcare challenge in Singapore. Epilog has won a test-bedding project in partnership with the National University Hospital and funded by Temasek Foundation.
FLUIDDA is amongst the top medical imaging providers of 2021
31 AUG 2021
Congrats to our partner FLUIDDA for being awarded Top Medical Imaging Provider of the year 2021 by Healthcare Tech Outlook, a leading Healthcare technology magazine.